Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FTLY6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,408
Award facts
- Contract value 100% obligated
- $16,408.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,408.26 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes on May 6, 2025, with an ultimate completion date of May 7, 2025. This competitive, firm fixed-price delivery order represents a continuation of the company's primary contract vehicle with DLA Troop Support Medical (SPE2DX), an Indefinite Delivery Contract valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, fulfills this delivery order from its corporate office location. Dupixent is a biologic medication used primarily for treating moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, supporting the Department of Defense's medical supply requirements.
AmerisourceBergen Drug Corp maintains a significant role as a critical vendor within the federal healthcare supply chain, providing comprehensive pharmaceutical and medical product support to military and veteran healthcare systems. The SPE2DX indefinite delivery contract serves as a flexible procurement vehicle enabling the company to supply a broad range of therapeutic medications, specialty drugs, vaccines, and medical devices to support Defense Health Agency operations and other federal healthcare entities. This delivery order was awarded without a set-aside designation through open competition, consistent with AmerisourceBergen Drug Corp's demonstrated capability to meet federal procurement standards for specialized pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DB25FTLY6?
SPE2DB25FTLY6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 6, 2025.
How much is contract SPE2DB25FTLY6 worth?
The government has obligated $16,408 on SPE2DB25FTLY6.
Is contract SPE2DB25FTLY6 an order under another contract?
Yes. SPE2DB25FTLY6 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FTLY6 competed?
The extent of competition for SPE2DB25FTLY6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award